JP2023536436A5 - - Google Patents
Info
- Publication number
- JP2023536436A5 JP2023536436A5 JP2023504816A JP2023504816A JP2023536436A5 JP 2023536436 A5 JP2023536436 A5 JP 2023536436A5 JP 2023504816 A JP2023504816 A JP 2023504816A JP 2023504816 A JP2023504816 A JP 2023504816A JP 2023536436 A5 JP2023536436 A5 JP 2023536436A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- chimeric
- seq
- stabilizing
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2007849 | 2020-07-24 | ||
| FR2007849 | 2020-07-24 | ||
| PCT/US2021/043077 WO2022020782A1 (en) | 2020-07-24 | 2021-07-23 | Compositions and methods for treating viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536436A JP2023536436A (ja) | 2023-08-25 |
| JP2023536436A5 true JP2023536436A5 (enExample) | 2024-07-30 |
Family
ID=77398656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504816A Pending JP2023536436A (ja) | 2020-07-24 | 2021-07-23 | ウイルス感染を治療するための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230304010A1 (enExample) |
| EP (1) | EP4185602A1 (enExample) |
| JP (1) | JP2023536436A (enExample) |
| CN (1) | CN116724059A (enExample) |
| AU (1) | AU2021314336A1 (enExample) |
| CA (1) | CA3190101A1 (enExample) |
| MX (1) | MX2023001049A (enExample) |
| WO (1) | WO2022020782A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3955967A4 (en) | 2019-04-17 | 2023-06-07 | Aadigen, LLC | PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES |
| WO2024187121A1 (en) * | 2023-03-08 | 2024-09-12 | Red Queen Therapeutics, Inc. | Combination therapies comprising stabilized sars-cov-2 peptides |
| WO2024187174A2 (en) | 2023-03-09 | 2024-09-12 | Aadigen, Llc | Compositions for treating cancer with kras mutations and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050113298A1 (en) * | 2003-09-15 | 2005-05-26 | The Brigham And Women's Hospital, Inc. | Receptor binding peptides derived from the SARS S protein |
| US7514530B2 (en) | 2004-04-26 | 2009-04-07 | Centre National De La Recherche Scientifique | Peptide carrier for delivering siRNA into mammalian cells |
| US7579318B2 (en) | 2005-12-06 | 2009-08-25 | Centre De La Recherche De La Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2012137036A1 (en) | 2011-04-04 | 2012-10-11 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2014053880A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2014053881A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2014053879A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2014053882A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| MX387665B (es) | 2014-12-24 | 2025-03-18 | Aadigen Llc | Péptidos, complejos, moléculas de carga y nanopartículas que contienen los mismos. |
| CA3025523A1 (en) * | 2016-05-27 | 2017-11-30 | Aadigen, Llc | Peptides and nanoparticles for intracellular delivery of genome-editing molecules |
| AU2018313940A1 (en) * | 2017-08-10 | 2020-03-05 | Aadigen, Llc | Peptides and nanoparticles for intracellular delivery of virus |
-
2021
- 2021-07-23 WO PCT/US2021/043077 patent/WO2022020782A1/en not_active Ceased
- 2021-07-23 JP JP2023504816A patent/JP2023536436A/ja active Pending
- 2021-07-23 CN CN202180062573.5A patent/CN116724059A/zh active Pending
- 2021-07-23 CA CA3190101A patent/CA3190101A1/en active Pending
- 2021-07-23 EP EP21756120.8A patent/EP4185602A1/en active Pending
- 2021-07-23 MX MX2023001049A patent/MX2023001049A/es unknown
- 2021-07-23 AU AU2021314336A patent/AU2021314336A1/en not_active Abandoned
- 2021-07-23 US US18/017,644 patent/US20230304010A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023536436A5 (enExample) | ||
| Langel | Handbook of cell-penetrating peptides | |
| US10421784B2 (en) | Cell penetrating peptides for intracellular delivery of molecules | |
| AU2009243187B2 (en) | Supercharged proteins for cell penetration | |
| US8242081B2 (en) | Cell penetrating peptides for intracellular delivery of molecules | |
| HRP20191852T1 (hr) | Polipeptidi | |
| US10287581B2 (en) | Cell penetrating peptides for intracellular delivery of molecules | |
| CA2909080C (en) | Methods, uses and compositions of tie2 agonists | |
| RU2010147076A (ru) | Аналоги инсулина специфичные к изоформам | |
| JP2006514602A5 (enExample) | ||
| JP2014508510A5 (enExample) | ||
| KR101647804B1 (ko) | 신규 세포투과 펩타이드 및 이의 용도 | |
| JP2012529891A5 (enExample) | ||
| JP2018088923A (ja) | 線維症予防又は治療剤 | |
| CN116724059A (zh) | 用于治疗病毒感染的组合物和方法 | |
| Ezzat et al. | Peptide-based matrices as drug delivery vehicles | |
| KR102166549B1 (ko) | 혈뇌장벽 투과성 펩티드 및 이를 포함하는 컨쥬게이트 | |
| KR102386478B1 (ko) | 신규한 세포 투과성 펩타이드 및 이의 용도 | |
| JP2020527546A5 (enExample) | ||
| EP1795539B1 (en) | Cell penetrating peptides for intracellular delivery of molecules | |
| KR102274876B1 (ko) | 신규한 세포 투과성 펩타이드 및 이의 용도 | |
| JP2011502521A5 (enExample) | ||
| KR100844497B1 (ko) | 세포침투성 융합단백질, 이를 코딩하는 폴리뉴클레오티드및 이를 발현하는 재조합 발현벡터 | |
| KR20260052131A (ko) | 조작된 트랜스페린 수용체 결합 펩티드 및 그의 제조 및 사용 방법 | |
| AU2024329222A1 (en) | Engineered transferrin receptor binding peptides as well as methods of making and using the same |